health FDA Clears Second Maggot Species for Wound Therapy, Expanding Cuprina Market Lead
The FDA has cleared Lucilia cuprina maggots for wound debridement. Singapore-based Cuprina Holdings now holds exclusive US clearance for both primary therapeutic fly species.
